Cite
APA Citation
Phillips, E. H., Devereux, S., Radford, J., Mir, N., Adedayo, T., Clifton-Hadley, L., & Johnson, R. (2019). toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial. Leukemia & lymphoma, 60(9), 2291–2294. http://access.bl.uk/ark:/81055/vdc_100132211949.0x00003b